Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 8/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23308722 | 0.83 | TP53 (0.44) | TP53TRPV1CA2NTRK2ALPL | |
| SCHEMBL4089780 | 0.81 | TP53 (0.67) | TP53TRPV1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL23308723 | 0.80 | TP53 (0.42) | TP53TRPV1ALPLL3MBTL1KDM4E | |
| SCHEMBL23308730 | 0.79 | SMN1; SMN2 (0.41) | TP53TRPV1POLBKDM4EALDH1A1 | |
| SCHEMBL23308706 | 0.76 | KDM4E (0.41) | TP53TRPV1KDM4E | |
| SCHEMBL7157289 | 0.75 | ALDH1A1 (0.48) | NTRK2L3MBTL1ALDH1A1 | |
| SCHEMBL27950767 | 0.75 | ALDH1A1 (0.37) | TP53TRPV1CA2ALPLL3MBTL1 | |
| SCHEMBL16364886 | 0.75 | MAPT (0.50) | TP53TRPV1CA2ALPLPOLB | |
| SCHEMBL21561693 | 0.74 | TP53 (0.58) | TP53TRPV1CA2L3MBTL1CA12 | |
| SCHEMBL11687379 | 0.73 | SLC9A1 (0.42) | CA2ALPLKCNH2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11781071-B2 | Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11781071-B2 | Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20210122979-A1 | CROSS-LINKING AGENT COMPOUND, LIQUID CRYSTAL ALIGNMENT COMPOSITION COMPRISING THE SAME, METHOD OF PREPARING LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING THE SAME | LG CHEM, LTD. (KR) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11781071-B2 | Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same | LPXN, LIG4, MACF1 | TP53 3366/4885TRPV1 4485/4885CA2 2546/4885 |
| US-20210122979-A1 | CROSS-LINKING AGENT COMPOUND, LIQUID CRYSTAL ALIGNMENT COMPOSITION COMPRISING THE SAME, METHOD OF PREPARING LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING THE SAME | LPXN, LIG4, MACF1 | TP53 3366/4885TRPV1 4485/4885CA2 2546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.